(Z)-5-Octen-2-one
General Information
Chemical name | (Z)-5-Octen-2-one |
CAS number | 22610-86-2 |
COE number | 11171 |
Flavouring type | substances |
FL No. | 07.236 |
Mixture | No |
Purity of the named substance at least 95% unless otherwise specified | |
Reference body | EFSA |
From webgate.ec.europa.eu
Computed Descriptors
Download SDF2D Structure | |
CID | 87927 |
IUPAC Name | oct-5-en-2-one |
InChI | InChI=1S/C8H14O/c1-3-4-5-6-7-8(2)9/h4-5H,3,6-7H2,1-2H3 |
InChI Key | NBFKNCBRFJKDDR-UHFFFAOYSA-N |
Canonical SMILES | CCC=CCCC(=O)C |
Molecular Formula | C8H14O |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 126.199 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 4 |
Complexity | 103.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B w I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A C A S A g A A C A A A A A A C I A K B S A A A A A A A g A A A I C A E A A A g A A B I A A Q A A A A A A g A A I A A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 17.1 |
Monoisotopic Mass | 126.104 |
Exact Mass | 126.104 |
XLogP3 | None |
XLogP3-AA | 1.7 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 9 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 1 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9883 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8851 |
P-glycoprotein Substrate | Non-substrate | 0.6388 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7699 |
Non-inhibitor | 0.6720 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8749 |
Distribution | ||
Subcellular localization | Plasma membrane | 0.5009 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8406 |
CYP450 2D6 Substrate | Non-substrate | 0.8515 |
CYP450 3A4 Substrate | Non-substrate | 0.6285 |
CYP450 1A2 Inhibitor | Inhibitor | 0.7766 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9462 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9533 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9536 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9750 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7751 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7590 |
Non-inhibitor | 0.8148 | |
AMES Toxicity | Non AMES toxic | 0.9517 |
Carcinogens | Carcinogens | 0.6148 |
Fish Toxicity | High FHMT | 0.9035 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9947 |
Honey Bee Toxicity | High HBT | 0.7648 |
Biodegradation | Ready biodegradable | 0.7821 |
Acute Oral Toxicity | III | 0.7050 |
Carcinogenicity (Three-class) | Non-required | 0.7313 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.6186 | LogS |
Caco-2 Permeability | 1.3700 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.7033 | LD50, mol/kg |
Fish Toxicity | 0.3341 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.4845 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Carbonyl compounds |
Intermediate Tree Nodes | Not available |
Direct Parent | Ketones |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Ketone - Organic oxide - Hydrocarbon derivative - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as ketones. These are organic compounds in which a carbonyl group is bonded to two carbon atoms R2C=O (neither R may be a hydrogen atom). Ketones that have one or more alpha-hydrogen atoms undergo keto-enol tautomerization, the tautomer being an enol. |
From ClassyFire